Background and objectives:This study aims to elucidate the prognostic implications of Epstein–Barr virus (EBV) infection in gastric carcinomas (GCs) through a systematic review and meta-analysis.Materials and Methods:In total, 57 eligible studies and 22,943 patients were included in this meta-analysis. We compared the prognoses of EBV-infected and non-infected GC patients. The subgroup analysis was performed based on the study location, molecular classification, and Lauren’s classification. This study was checked according to the PRISMA 2020. The meta-analysis was performed using the Comprehensive Meta-Analysis software package.Results:EBV infection was found in 10.4% (95% confidence interval (CI) 0.082–0.131) of GC patients. The EBV-infected GC patients had a better overall survival compared with the EBV-non-infected GC patients (hazard ratio (HR) 0.890, 95% CI 0.816–0.970). In the subgroup analysis based on molecular classification, no significant differences were found between EBV+ and microsatellite instability and microsatellite stable (MSS)/EBV− subgroups (HR 1.099, 95% CI 0.885–1.364 and HR 0.954, 95% CI 0.872–1.044, respectively). In the diffuse type of Lauren’s classification, EBV-infected GCs have a better prognosis compared with the EBV-non-infected GCs (HR 0.400, 95% CI 0.300–0.534). The prognostic impact of EBV infection was found in the Asian and American subgroups but not in the European subgroup (HR 0.880, 95% CI 0.782–0.991, HR 0.840, 95% CI 0.750–0.941, and HR 0.915, 95% CI 0.814–1.028).Conclusions:EBV infection is a favorable survival factor for GCs. However, the prognostic implications of EBV infection in the new molecular classification are not clear.